Literature DB >> 27121739

Radiological changes on CT after stereotactic body radiation therapy to non-spine bone metastases: a descriptive series.

Nicholas Chiu1, Linda Probyn2, Srinivas Raman1, Rachel McDonald1, Ian Poon1, Darby Erler1, Drew Brotherston1, Hany Soliman1, Patrick Cheung1, Hans Chung1, William Chu1, Andrew Loblaw1, Nemica Thavarajah1, Catherine Lang2, Lee Chin3, Edward Chow4, Arjun Sahgal1.   

Abstract

BACKGROUND: In recent years, stereotactic body radiation therapy (SBRT) has become increasingly used for the management of non-spine bone metastases. Few studies have examined the radiological changes in bone metastases after treatment with SBRT and there is no consensus about what constitutes radiologic response to therapy. This article describes various changes on CT after SBRT to non-spine bone metastases in eight selected cases.
METHODS: A retrospective review was conducted for patients treated with SBRT to non-spine bone metastases between November 2011 and April 2014 at Sunnybrook Health Sciences Centre. A musculoskeletal radiologist identified eight illustrative cases of interest and provided a description of the findings.
RESULTS: Different radiological changes following SBRT were described, including: remineralization of lytic bone metastases, demineralization of sclerotic bone metastases, pathologic fracture, size progression and response in different lesions, as well as lung fibrosis after SBRT to a rib metastasis.
CONCLUSIONS: We reviewed the radiological images of eight selected cases after SBRT to nonspine bone metastases and a number of characteristic findings were highlighted. We recommend future studies to correlate radiologic changes with clinical outcomes including pain relief, toxicity and long-term local control.

Entities:  

Keywords:  CT; Stereotactic body radiation therapy (SBRT); non-spine bone metastases

Mesh:

Year:  2016        PMID: 27121739     DOI: 10.21037/apm.2016.03.01

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  2 in total

Review 1.  Translational and basic science opportunities in palliative care and radiation oncology.

Authors:  Mai Anh Huynh; Alexander Spektor
Journal:  Ann Palliat Med       Date:  2019-07

2.  [Single dose of 24 Gy or 3-fraction SBRT regimen in the treatment of oligometastatic cancer? : A phase III multi-center trial].

Authors:  Hossein Hemmatazad; Etienne Mathier; Daniel M Aebersold; Mohamed Shelan
Journal:  Strahlenther Onkol       Date:  2021-06-29       Impact factor: 3.621

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.